Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1151044

registered interest
date	21/10/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Immigration: Windrush Generation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, when she plans to publish the Wendy Williams' report on the Windrush lessons learned review.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	2636
answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>The Home Secretary has not yet received the final report from Wendy Williams. On receipt, it will be published as soon as practicable.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/11/2019 15:14:45 answering member 4455 label Biography information for Seema Kennedy
tabling member	151 label Biography information for Tom Brake

1150326

registered interest
date	17/10/2019
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Brexit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, with reference to the Answer of 4 October 2019 to Question 290576 on Low incomes: Food, how many exit scenarios the Government has planned for; what the cost of those plans are; and what form those plans take.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	1534
answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>The Prime Minister has negotiated a new deal which would ensure that the UK leaves the EU in an orderly and friendly way.</p><p>However, the Government is also well prepared for a no deal scenario. The Treasury has made over £8.3 billion available to prepare for Brexit, including £2.1 billion in August this year to increase preparations for leaving without a deal.</p><p>The food industry is experienced in dealing with scenarios that can affect food supply, from adverse weather damaging crops in other countries to transport issues abroad. The Government has been meeting weekly with industry and retailers to make sure we are prepared for all exit scenarios.</p><p>The Government remains committed to providing support to those who need it most, and the national benefit system will continue to provide a strong safety net, delivering over £200 billion in support this year. In particular, the Government continues to spend over £95 billion a year on welfare benefits. This includes a well-established system of hardship payments, benefit advances and budgeting loans as an additional safeguard for those who need them.</p><p> </p> answering member constituency Rochford and Southend East answering member printed James Duddridge question first answered 29/10/2019 13:24:50 answering member 1559 label Biography information for Sir James Duddridge
tabling member	151 label Biography information for Tom Brake

1149972

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase uptake of the flu vaccine by social care staff.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	844
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>Flu vaccination is recommended for all frontline social care workers. This should be provided by their employer as part of the organisation’s policy for the prevention of the transmission of flu to help protect both staff and those that they care for. To help increase uptake rates for social care workers, NHS England and NHS Improvement have a scheme to complement employers responsibilities so that vaccination is also available for social care and hospice staff from their general practitioner or community pharmacy.</p><p> </p><p>For this coming winter, Public Heath England have developed brand new resources to encourage social care worker vaccination. These resources are available at the following link:</p><p> </p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview</a></p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 14:18:51 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149209

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the August 2019 British Nuclear Medicine Society's open letter to the Prime Minister on radioisotope delivery, what assessment his Department has made of the effect on the costs of radioisotope delivery of the UK leaving the EU without a deal.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	400
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 402 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149210

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to research conducted by 38 degrees showing that 571 people in Carshalton and Wallington have type 1 diabetes and rely on daily insulin, what assessment his Department has made of the distribution and number of diabetes sufferers in the UK; and what steps his department has taken to secure undisrupted supply of insulin across the UK in the event of the UK leaving the EU without a deal.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	401
answer	answer is ministerial correction date of answer 23/10/2019 answer text <p>The number of people registered with diabetes at a general practitioner (GP) practice in 2017-18 by clinical commissioning group and diabetes type in England can be found in the attached table.</p><p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should help to ensure the uninterrupted supply of medicines and medical products, including insulin, once we have left the EU.</p><p>As part of our EU exit preparations, we are implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p><p>All three suppliers of insulin have publicly stated that they have significantly increased their United Kingdom stockpiles, and have met the Government request that they hold at least six weeks’ worth of extra stock in addition to their usual operational stocks.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/10/2019 16:56:42 answering member 4380 label Biography information for Jo Churchill attachment 1 file name PQ401England CCG level.docx title PQ401 table
tabling member	151 label Biography information for Tom Brake

1149361

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's policies of the matters raised in the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	402
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149365

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if the NHS will allocate additional funding to NHS trusts to cover increased costs incurred for the supply of medical isotopes in the event that the UK leaves the EU without a deal.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	403
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149366

registered interest
date	15/10/2019
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Business: Northern Ireland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, with reference to the Prime Minister's proposed EU exit deal, what assessment his Department has made of the economic effect on businesses in Northern Ireland of the imposition of checks on both the North-South and East-West border.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	404
answer	answer is ministerial correction date of answer 23/10/2019 answer text <p>The new Withdrawal Agreement and Political Declaration, agreed between the UK and the EU on 17 October, protects the economy of Northern Ireland and Ireland by ensuring that all businesses can continue to trade easily across the North-South border without checks or controls at, or near the border.</p><p> </p> answering member constituency Rochford and Southend East answering member printed James Duddridge question first answered 23/10/2019 15:55:11 answering member 1559 label Biography information for Sir James Duddridge
tabling member	151 label Biography information for Tom Brake

1149367

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if his Department will respond to the concerns raised in that letter about the timely delivery of medical radioisotopes to the North of England, the South West of England, Wales, Scotland and Northern Ireland.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	405
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 403 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149369

registered interest
date	15/10/2019
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Industry: Northern Ireland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, with reference to the Prime Minister's proposed EU exit deal, when his Department last met with representatives of Northern Irish industry to discuss the effect on that industry of the imposition of a North-South and an East-West border.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	419
answer	answer is ministerial correction date of answer 23/10/2019 answer text <p>The department has engaged extensively with representatives of businesses, industry groups and trade unions from Northern Ireland. This includes through the Government’s Alternative Arrangements Business Advisory Group. Ministers are continuing to engage with representatives from all sectors of the Northern Ireland economy.</p><p>The Government's revised deal provides a new and unique solution for Northern Ireland – they will continue to be part of the UK Customs Union, but with access to EU markets without a hard border. The Government has made clear commitments to ensure unfettered access for Northern Ireland businesses to the whole UK internal market.</p><p> </p> answering member constituency Rochford and Southend East answering member printed James Duddridge question first answered 23/10/2019 15:58:25 answering member 1559 label Biography information for Sir James Duddridge
tabling member	151 label Biography information for Tom Brake